Cargando…
Methyl Jasmonate Cytotoxicity and Chemosensitization of T Cell Lymphoma In Vitro Is Facilitated by HK 2, HIF-1α, and Hsp70: Implication of Altered Regulation of Cell Survival, pH Homeostasis, Mitochondrial Functions
Methyl jasmonate (MJ) displays antineoplastic potential against numerous neoplastic cells. However, several mechanistic aspects of its antineoplastic action against malignancies of T cell origin remain elusive. The present investigation reports the novel targets of MJ and mechanistic pathways of MJ-...
Autores principales: | Goel, Yugal, Yadav, Saveg, Pandey, Shrish Kumar, Temre, Mithlesh Kumar, Singh, Vinay Kumar, Kumar, Ajay, Singh, Sukh Mahendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954117/ https://www.ncbi.nlm.nih.gov/pubmed/33716751 http://dx.doi.org/10.3389/fphar.2021.628329 |
Ejemplares similares
-
Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity
por: Temre, Mithlesh Kumar, et al.
Publicado: (2022) -
Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate
por: Yadav, Saveg, et al.
Publicado: (2019) -
Tumor Decelerating and Chemo-Potentiating Action of Methyl Jasmonate on a T Cell Lymphoma In Vivo: Role of Altered Regulation of Metabolism, Cell Survival, Drug Resistance, and Intratumoral Blood Flow
por: Goel, Yugal, et al.
Publicado: (2021) -
Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies
por: Yadav, Saveg, et al.
Publicado: (2017) -
An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
por: Temre, Mithlesh Kumar, et al.
Publicado: (2022)